These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12732689)

  • 1. Whole-body thyroid tumor 123I scintigraphy.
    Gerard SK
    J Nucl Med; 2003 May; 44(5):852. PubMed ID: 12732689
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroid stunning after (131)I diagnostic whole-body scanning.
    McMenemin RM; Hilditch TE; Dempsey MF; Reed NS
    J Nucl Med; 2001 Jun; 42(6):986-7. PubMed ID: 11390566
    [No Abstract]   [Full Text] [Related]  

  • 3. [Iodine scintigraphy of differentiated thyroid carcinoma].
    Nakata K; Tsukamoto E; Ito K; Kato C; Furudate M
    Rinsho Hoshasen; 1988 May; 33(5):589-90. PubMed ID: 3047462
    [No Abstract]   [Full Text] [Related]  

  • 4. 123I imaging in the follow-up of differentiated thyroid cancer.
    Fenwick JD; Mallick UK; Perros P
    Clin Oncol (R Coll Radiol); 2001; 13(4):314. PubMed ID: 11554639
    [No Abstract]   [Full Text] [Related]  

  • 5. Postoperative uptake in the thyroid bed, not tumor stage, determines the usefulness of diagnostic whole body scan in the first year after ablation with radioiodine.
    Rosário PW; Barroso AL; Purisch S
    Thyroid; 2007 Aug; 17(8):803-4. PubMed ID: 17708716
    [No Abstract]   [Full Text] [Related]  

  • 6. Radioiodine ablation outcomes after imaging with 123I or 131I: is no news good news?
    Burniston MT; Wilson DJ
    J Nucl Med; 2008 Jan; 49(1):166; author reply 166-7. PubMed ID: 18165699
    [No Abstract]   [Full Text] [Related]  

  • 7. The case for obtaining a diagnostic whole-body scan prior to iodine 131 treatment of differentiated thyroid cancer.
    McDougall IR
    Thyroid; 2009 Aug; 19(8):811-3. PubMed ID: 19645613
    [No Abstract]   [Full Text] [Related]  

  • 8. Artifactual I-131 activity in the hairs after thyroid remnant ablation.
    Bhargava P; Choi WS
    Thyroid; 2006 Nov; 16(11):1187-9. PubMed ID: 17123350
    [No Abstract]   [Full Text] [Related]  

  • 9. [Procedural guideline for Iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma (version 5)].
    Verburg FA; Schmidt M; Kreissl MC; Grünwald F; Lassmann M; Hänscheid H; Hohberg M; Luster M; Dietlein M
    Nuklearmedizin; 2019 Jun; 58(3):228-241. PubMed ID: 31035298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallbladder visualization during post-therapy iodine-131 imaging of thyroid carcinoma.
    Achong DM; Oates E; Lee SL; Doherty FJ
    J Nucl Med; 1991 Dec; 32(12):2275-7. PubMed ID: 1744714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid stunning.
    Medvedec M
    J Nucl Med; 2001 Jul; 42(7):1129-31. PubMed ID: 11438638
    [No Abstract]   [Full Text] [Related]  

  • 12. The low utility of pretherapy scans in thyroid cancer patients.
    Schlumberger MJ; Pacini F
    Thyroid; 2009 Aug; 19(8):815-6. PubMed ID: 19645614
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole body scintigram with 131I before and immediately after the ablation or tumor dose in patients with differentiated thyroid carcinoma and the effect of endogenous stimulation of thyrostimulating hormone on thyroglobulin in same patients.
    Malesevic M; Stefanovic L; Popovic S; Prvulovic M; Selir Z; Milkovic L
    Radiobiol Radiother (Berl); 1987; 28(5):651-3. PubMed ID: 3441615
    [No Abstract]   [Full Text] [Related]  

  • 15. Stunning after tracer dosimetry.
    Diehl M; Grünwald F
    J Nucl Med; 2001 Jul; 42(7):1129. PubMed ID: 11438639
    [No Abstract]   [Full Text] [Related]  

  • 16. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
    Gerard SK; Dam HQ
    Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic I-123 scintigraphy to assess potential breast uptake of I-131 before radioiodine therapy in a postpartum woman with thyroid cancer.
    Hsiao E; Huynh T; Mansberg R; Bautovich G; Roach P
    Clin Nucl Med; 2004 Aug; 29(8):498-501. PubMed ID: 15249829
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyroid stunning.
    Coakley AJ
    Eur J Nucl Med; 1998 Mar; 25(3):203-4. PubMed ID: 9580850
    [No Abstract]   [Full Text] [Related]  

  • 19. Exercise-induced radio-iodine accumulation in scalp and hair during admission of 131I therapy for thyroid cancer.
    Zakavi SR; Kakhki VD
    Thyroid; 2006 Nov; 16(11):1185-6. PubMed ID: 17123349
    [No Abstract]   [Full Text] [Related]  

  • 20. Contamination of a bracelet following iodine-131 therapy: a case report.
    Bybel B; Beebe W; Kim BY; Faiman C
    J Nucl Med Technol; 2000 Dec; 28(4):257-8. PubMed ID: 11142327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.